Stay updated on Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.4 to v3.5.5, signaling a small update to the page template or CMS without changing the study information.
    Difference
    0.1%
    Check dated 2026-06-05T12:10:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.3 to v3.5.4. This reflects a minor update to the page version metadata and does not alter core study content.
    Difference
    0.1%
    Check dated 2026-05-15T02:24:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, representing a small, non-substantive update to the page. The core study details and data are not indicated to have changed.
    Difference
    0.1%
    Check dated 2026-04-30T17:35:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:24:36.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:28:52.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T11:44:15.000Z thumbnail image

Stay in the know with updates to Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.